NOLIMIT BIO Trademark
Trademark Overview
On Tuesday, August 22, 2023, a trademark application was filed for NOLIMIT BIO with the United States Patent and Trademark Office. The USPTO has given the NOLIMIT BIO trademark a serial number of 98144336. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, April 24, 2025. The NOLIMIT BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Biomedical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Research on the subject of pharmaceuticals; Biotechnology research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechn...
General Information
| Serial Number | 98144336 |
| Word Mark | NOLIMIT BIO |
| Filing Date | Tuesday, August 22, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, April 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | NO LIMIT BIO |
| Goods and Services | Biomedical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Research on the subject of pharmaceuticals; Biotechnology research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 21, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Buenos Aires CABA 1406
AR |
Trademark Events
| Event Date | Event Description |
| Friday, August 25, 2023 | NEW APPLICATION ENTERED |
| Thursday, September 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, April 20, 2024 | ASSIGNED TO EXAMINER |
| Sunday, April 21, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Sunday, April 21, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 23, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 31, 2024 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, December 31, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, April 23, 2024 | SUSPENSION LETTER WRITTEN |
| Tuesday, April 23, 2024 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 31, 2024 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, March 31, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, April 23, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, April 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 23, 2025 | ASSIGNED TO LIE |
| Thursday, April 24, 2025 | SUSPENSION LETTER WRITTEN |
| Thursday, April 24, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, April 24, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
